tirzepatide surmount trials once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Tirzepatide Further Cements Weight Loss

As with any emerging treatment, we know our patients have questions

A 2021 study found that individuals on a higher dose of GLP-1 lost an average of 15% (34 lbs) weight loss, with 44% of that weight loss (15 lbs) coming from muscle (Wilding et al, 2021)

Long-term prediabetes prevention depends on sustainable habits such as regular physical activity, balanced nutrition, and ongoing care with a healthcare provider

Shes heard that there you just tell them a weight that would put you at a BMI of 27 or more, and theyll prescribe without validating it. Other women I spoke with said they obtained brand-name, FDA-approved GLP-1s like Zepbound and Wegovy through a health care provider willing to prescribe them off-label to people with lower BMIs